Kim Yuri, Kim Myungjin, Kim Dai Woo, Rho Seungsoo
Department of Ophthalmology, Bundang CHA Medical Center, CHA University, Seongnam 13496, Republic of Korea.
Department of Ophthalmology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.
J Clin Med. 2023 Jun 27;12(13):4293. doi: 10.3390/jcm12134293.
This case report describes the successful use of a XEN gel stent for controlling intraocular pressure (IOP) in a patient who had previously undergone scleral encircling for rhegmatogenous retinal detachment. The patient had very limited mobile conjunctiva due to scarring caused by the earlier surgery, which limited their options for glaucoma surgery. The XEN gel stent, a minimally invasive glaucoma surgery (MIGS) procedure that does not require opening the conjunctiva, was implanted in the subconjunctival space using an ab interno approach. Postoperative blebs were imaged using anterior segment optical coherence tomography, and IOP was monitored over six months. This study found that the XEN gel stent effectively controlled the IOP, and there were no complications during or after surgery. This case report may expand the indication for the XEN gel stent, which could be considered a viable option for patients who have undergone scleral buckling and have limited mobile conjunctiva.
本病例报告描述了一名先前因孔源性视网膜脱离接受巩膜环扎术的患者成功使用XEN凝胶支架控制眼压的情况。由于早期手术造成的瘢痕，患者结膜活动度非常有限，这限制了其青光眼手术的选择。XEN凝胶支架是一种无需打开结膜的微创青光眼手术（MIGS），通过内路方法植入结膜下间隙。使用眼前节光学相干断层扫描对术后滤过泡进行成像，并对眼压进行了六个月的监测。本研究发现，XEN凝胶支架有效地控制了眼压，手术期间及术后均无并发症。本病例报告可能会扩大XEN凝胶支架的适应证范围，对于接受过巩膜扣带术且结膜活动度有限的患者，它可被视为一种可行的选择。
